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Trends in Biotechnology

governance in the EU, realize the subsidiarity principle as strengthened by
the Lisbon Treaty ii , and focus on regulating issues where there is consensus
across the EU. Therefore, we propose
that the EC initiates an investigation of
this model. The approach towards coexistence policies in the EU may serve
as an example.
In the third of our articles [14], we
present certain reform details regarding the postauthorization requirements as well as discuss the current
political landscape in the EU and
whether any regulatory reform is currently feasible.
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As public interest advocates, policy
experts, bioethicists, and scientists,
we call for a course correction in
public discussions about heritable
human genome editing. Clarifying
misrepresentations, centering societal consequences and concerns,
and fostering public empowerment
will support robust, global public engagement and meaningful deliberation about altering the genes of
future generations.
Heritable Human Genome Editing:
Nearing a Critical Juncture
The impending decision about whether to
develop and use heritable human genome
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Box 1. Why Another Statement?
We write as a group of public interest advocates, social science and humanities scholars, ethicists, policy experts,
and life scientists who share a commitment to social justice, human rights, and democratic governance of science
and technology. In January 2019, we met at the Brocher Foundation near Geneva, Switzerland to assess and discuss public engagement and the governance of heritable human genome editing. As an international group including
both academic experts and civil society representatives, we necessarily produced a different kind of statement.
Nearly all previous statements on heritable human genome editing have been authored by groups dominated by
scientists and bioethics professionals and based in scientiﬁc and medical perspectives. By contrast, this statement foregrounds social justice, human rights, and civil society perspectives. Its aim is to reorient the conversation around heritable human genome editing by identifying misrepresentations and misunderstandings that
muddy the discourse and by encouraging a robust consideration of the social, historical, and commercial contexts that would inﬂuence the development of heritable human genome editing and shape its societal effects.

modiﬁcation carries high stakes for our
shared future. Deciding to proceed with altering the genes of future children and
generations would mean abandoning the
restraint urged by the United Nations
(UN) General Assembly’s formal endorsement of the Universal Declaration on the
Human Genome and Human Rights [1]
and required by the laws and regulations
of more than 50 nations (F. Baylis et al.,
in preparation), including 29 that have
ratiﬁed the Oviedo Convention, a binding
international treaty [2]. Policymakers put
these prohibitions in place to protect
human rights and the fundamental equality
of all people; to safeguard the physical,
psychological, and social wellbeing of children; and to avert the emergence of a new
eugenics.
Despite the persistence of these fundamental and widely shared concerns, a
small but vocal group of scientists and bioethicists now endorse moving forward
with heritable human genome editingi,ii
[3]. They have taken it as their task to decide how we might proceed toward altering the genes of future children and
generations. In fact, the question at hand
is whether to proceed at all. Neither the responsibility for answering that question
nor the authority to answer it can be theirs
alone (Box 1).
We contest moves toward reproductive
use of human genome modiﬁcation and
afﬁrm the need for broad societal
352
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consensus before any decision about
whether to proceed is made. We insist
on the need for genuine public engagement that is inclusive, global, transparent,
informed, open in scope, supported by resources, and given adequate time.
Toward that end, we call for an urgently
needed course correction (Box 2) along
three dimensions.
First, we need to address and clarify several
misrepresentations that have distorted public understanding of heritable human genome modiﬁcation.
Second, we must reorient the conversation
by foregrounding societal consequences
and undertaking a thorough analysis of
threats to equality.
Third, we need criteria for ‘public empowerment’: robust public engagement that
promotes democratic governance through
shared decision-making [4].

Clarifying Misconceptions
Informed deliberations will require setting
the record straight on key points about
heritable human genome editing that have
repeatedly been presented in a confusing
or inaccurate way, distorting understanding and creating barriers to meaningful
public engagement.
Perhaps the most fundamental and widespread misrepresentation is that heritable

human genome editing is needed to treat
or prevent serious genetic diseases. Deliberations about heritable human genome
editing should hence acknowledge these
basic points:
• Heritable human genome editing
would not treat, cure, or prevent disease in any existing person. Instead,
it would modify the genes of future
children and generations through the
intentional creation of embryos with
altered genomes. This fact makes it
categorically distinct from somatic
gene therapies. Heritable human genome editing should be understood
not as a medical intervention, but as
a way to satisfy parental desires for
genetically related children or for children with speciﬁc genetic traits.
• Modifying genes in early embryos,
gametes, or gamete precursor cells
could produce unanticipated biological
effects in resulting children and in their
offspring, creating harm rather than
preventing it. Heritable human genome
editing would also require and normalize the use of in vitro fertilization
(IVF), exposing healthy women to signiﬁcant health burdens [4].
• Prospective parents at risk of transmitting a genetic condition already
have several options to avoid doing
so, should they ﬁnd them acceptable.
For example, prospective parents
may seek to have unaffected children
via third-party gametes or adoption.
• In nearly every case, prospective parents at risk of transmitting a genetic
condition who wish to avoid doing so
and to have genetically related children can accomplish this with the
existing embryo screening technique
preimplantation genetic diagnosis
(PGD) [5]. While PGD also raises troubling ethical questions about what
kind of lives we welcome into the
world, modifying or introducing traits
through genome editing would vastly
intensify these concerns. Genome
editing cannot be considered an

Trends in Biotechnology

Box 2. The Need for Course Correction

reinvigorated by the availability of heritable human genome editingiv [6,7]. These
pernicious ideas increase stigma and
discrimination
against
those
considered genetically disadvantaged,
including disabled people and communities, and undermine the fundamental
equality of all people.
More recently, the need for broad societal consensus was reafﬁrmed in the call for a global moratorium on
heritable human genome editing by an international group of scientists and ethicists, including two of the three
• Outcomes in related biotechnological
scientists most often recognized as CRISPR pioneers [5]. Subsequent endorsements of their statementvii–ix
spheres provide examples of the likely
[10] and additional calls for a moratorium from scientists, bioethicists, and biotechnology executivesx [11] protrajectory of heritable human genome
vide a welcome reminder that enthusiasm for heritable human genome editing is far from universally shared in
scientiﬁc and industry circles. The proposed moratorium would allow time to develop the more substantive,
editing if commercialized. These include
inclusive, and empowering forms of public engagement needed in deliberations about heritable human
the promotion of social sex selection by
genome editing.
fertility clinics and of unproven and risky
‘treatments’ by commercial stem cell
clinics.
alternative to PGD, because PGD because their genetic underpinnings are
would remain a necessary step in any too complexiii. This point is important but
embryo editing procedure.
not decisive. Some prospective parents Public engagement and empowerment
are likely to ﬁnd fertility clinics’ marketing are likely to reveal additional concerns
appeals compelling even when the genetic that have not yet surfaced, particularly if
Centering Societal
Consequences and Concerns
modiﬁcations offered are dubious. It is we commit to including and listening to a
To date, most conversations about herita- clear that social inequality and discrimina- broad range of voices and perspectives.
ble human genome editing have neither tion can be spurred by the mere percepadequately analyzed its societal context tion that some humans are biologically Fostering Public Empowerment
nor meaningfully explored its social justice ‘better’ than others.
Despite widespread recognition that deciand human rights implications, despite
sions about this powerful technology
their seriousness.
Deliberations about heritable human ge- cannot be made by scientists alone,
nome modiﬁcation must seriously investi- public involvement is often devalued,
We share widespread concerns that the ac- gate the implications of social and undermined, or limited to predetermined
cumulation of individual choices shaped by historical dynamics such as these:
issues (e.g., selecting conditions for
cultural and market forces could result
which germline editing should be availin heritable human genome modiﬁcation • Competitive pressures to ‘get ahead’, able). What is often proposed in lieu of
coupled with commercial incentives in
ushering in a new form of eugenics. Particugenuine public engagement is a topthe fertility industry (especially where it down project of educating the uninformed
larly troubling is the prospect that heritable
operates in the private sector), could public with the explicit goal of engineering
human genome editing would be used in
foster the adoption of heritable human acceptance. A related approach sidelines
efforts to alter a wide range of human
genome editing by those able to afford public engagement by framing heritable
traits. Although several recent proposals
it. Unequal access to perceived genetic human genome modiﬁcation as inevitable
would limit it to genes associated with
‘upgrades’ could then exacerbate the while ignoring social and medical alternamedical conditions, none adequately
grapples with how the tenuous distincrecent dramatic rise in socioeconomic tives, as well as the numerous policies
tion between ‘therapy’ and ‘enhancement’
inequality.
prohibiting it.
uses would be deﬁned or enforced. Even • Racism and xenophobia are resurgent
well-intentioned efforts to restrict its use to
around the world, fueled by discredited Public empowerment requires that particispeciﬁed conditions would be unlikely to
scientiﬁc and popular assumptions pants set the scope and framework of
hold, especially under the self-regulatory
about biological differences among ra- assessment. All facets of the question –
arrangements often envisioned.
cially categorized populations. Eugenic especially whether heritable human gethinking, which aims to ‘improve’ human- nome modiﬁcation should be pursued
Some dismiss such concerns, saying that
ity through genetic and reproductive at all – must remain open to debate. Deit will not be possible to genetically entechnologies and practices, persists liberations must proceed with a clear,
hance traits like intelligence or appearance
in popular discourse and could be shared understanding of what is in
The organizing committee of the 2015 International Summit on Human Gene Editing asserted that clinical
use of germline editing should not proceed without ‘broad societal consensus’v. Instead of sustained commitment and the allocation of signiﬁcant resources toward this prerequisite, we have seen steady efforts to
weaken it. Perhaps the clearest example came from the organizing committee of the 2018 International
Summit on Human Genome Editing. Meeting in the shadow of He Jiankui’s utterly unethical experiments,
this group issued a call for a ‘translational pathway to germline editing’, with only a cursory mention of
‘attention to societal effects’vi.
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question and at stake and with transpar- wise, democratic decisions about the
ency about ﬁnancial or other interests shared future we aspire to build.
shaping the conversations. Further, the
outcomes of public deliberations need Acknowledgments
to be taken into account by policymakers The authors gratefully acknowledge the Brocher
and integrated into formal decision-making Foundation (www.brocher.ch), Geneva, Switzerland, for hosting the workshop that initiated this
processes.
statement and for generously providing ﬁnancial

support for Open Access publication. We also

Robust public engagement must also be
thank Kathrin Martin for her assistance.
global and inclusive, involving a range of
publics whose voices have, to date, been
Resources
overlooked or minimized [8]. While scien- iwww8.nationalacademies.org/onpinews/newsitem.
tists’ contributions are important, their aspx?RecordID=11282018b
voices should not dominate; social values iihttp://nufﬁeldbioethics.org/project/genome-editingand implications must be at the center. human-reproduction
iii
Thus, in addition to scholars in the social www.nytimes.com/2017/08/04/science/geneediting-embryos-designer-babies.html
sciences and humanities, legal and policy iv
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Concluding Remarks
No decision about whether to pursue heritable human genome modiﬁcation can be
legitimate without broadly inclusive and
substantively meaningful public engagement and empowerment. Such deliberations may be challenging and messy. They
will take time and organizing them will necessitate creativity, hard work, and signiﬁcant human and ﬁnancial resources [9].
The course correction proposed here is essential to these efforts.
We must in the meantime respect the predominant policy position against pursuing
heritable human genome modiﬁcation, if
we are to prevent individual scientists or
small committees from making this momentous decision for us all. This will preserve time to cultivate an informed and
engaged public that can consider and discuss the societal consequences of altering
the genes of future generations and make
354
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